Procedures involving phlebotomy are critical for obtaining diagnostic blood specimens and represent a well known and recognized problem, probably among the most important issues in laboratory medicine. The aim of this report is to show spurious hyperkalemia and hypocalcemia due to inadequate phlebotomy procedure. The diagnostic blood specimens were collected from a male outpatient 45 years old, with no clinical complaints. The tubes drawing order were as follows: i) clot activator and gel separator (serum vacuum tube), ii) K 3 EDTA, iii) a needleless blood gas dedicatedsyringe with 80 I.U. lithium heparin, directly connected to the vacuum tube holder system. The laboratory testing results from serum vacuum tube and dedicated syringe were 4.8 and 8.5 mmol/L for potassium, 2.36 and 1.48 mmol/L for total calcium, respectively. Moreover 0.15 mmol/L of free calcium was observed in dedicated syringe. A new blood collection was performed without K 3 EDTA tube. Diff erent results were found for potassium (4.7 and 4.5 mmol/L) and total calcium (2.37 and 2.38 mmol/L) from serum vacuum tube and dedicated syringe, respectively. Also free calcium showed diff erent concentration (1.21 mmol/L) in this new sample when compared with the fi rst blood specimen. Based on this case we do not encourage the laboratory managers training the phlebotomists to insert the dedicated syringes in needle-holder system at the end of all vacuum tubes. To avoid double vein puncture the dedicated syringe for free calcium determination should be inserted immediately after serum tubes before EDTA vacuum tubes.
Introduction
The preanalytical phase (PP) is nowadays recognized as the most vulnerable part of the total testing process (1) . The PP procedures involving phlebotomy are critical for obtaining diagnostic blood specimens: on the whole they represent a well known and recognized problem, probably among the most important issues in laboratory medicine (2) (3) (4) (5) . Lippi and Simundic recently advised to think outside the box and to address the extra-analytical processes that are more vulnerable to errors (6) . With this aim, we demonstrate here that incorrect procedures during phlebotomy can be a source of spurious hyperkalaemia and hypocalcemia in patients' samples.
Case report
A 45 years old male outpatient, with no apparent clinical complaints, wheelchair dependent, calls to our laboratory accredited by DICQ® (DICQ is a National System of Accreditation from Brazilian Society of Clinical Analyses based on ISO 15189 docu-Lima-Oliveira G. et al.
Phlebotomy management case report ment), asking for a blood specimen collection at home, for performing a series of routine laboratory tests prescribed by his physician. The tests are the: total cholesterol (CHOL), HDL-cholesterol (HDL), triglycerides (TG), sodium (Na), potassium (K), total calcium (tCa), free calcium (fCa), urea, creatinine (CREA), total protein (TP), albumin (ALB), alkaline phosphatase (ALP) and routine blood count with platelets (CBC). The patient was asked to observe 12-hours overnight fasting and the blood collection was scheduled for 7 am, 3 work days after his call. Before blood collection, the median cubital vein was located on the left forearm using only a subcutaneous tissue transilluminator device (Venoscópio IV plus, Duan do Brasil, Sao Paulo, Brazil) -without tourniquet -to prevent interference from venous stasis (7) (8) (9) , and blood samples were collected using a 20-G straight needle (BD Vacuntainer ® Becton, Dickinson and Company Franklin Lakes, NJ, USA) connected to the holder, directly into the vacuum tubes (Greiner Bio-One GmbH, Kremsmünster, Austria). The order of diff erent types of tube fi lling was: a) clot activator and gel separator tube, b) K 3 EDTA tube for CBC and c) a blood gas dedicated-syringe (Pico 50® with 80 I.U. lyophilized electrolyte-balanced lithium heparin, Radiometer Medical ApS, Denmark) without needle, which was directly connected to the needleholder system in order to avoid double vein puncture. After collection, the tubes were properly mixed and transported from patient's house to the core laboratory by car at 20 ± 2 °C in upright position inside a transport box. The blood into syringe was transported at 4 ± 1 °C, as recommended by clinical laboratory standard institute C31-A2 document (10) . The blood specimens (serum tube, cell blood count tube and dedicated syringe) arrived in core laboratory about one hour after blood collection and were immediately processed and analyzed (< 15 min from the arrival time). The dedicated syringe was properly mixed and the free calcium was measured by ion-selective electrode on ABL 700® (Radiometer Medical ApS, Brønshøj, Denmark), according to the manufacturer's specifi cations and using proprietary reagents. Whole blood for CBC was gently mixed and analyzed on Sysmex® XE-2100D, Automated Hematology Analyzer (Sysmex Corporation®, Kobe, Japan). Serum vacuum tube was centrifuged at 1500 x g for 10min at room temperature. In sequence, the laboratory tests on serum were performed on the primary blood tube on Cobas® 6000 < c501 > module (Roche Diagnostics GmbH, Penzberg, Germany), according to the manufacturer's specifi cations and using proprietary reagents. All laboratory instruments had been previously calibrated against appropriate proprietary reference standard material and verifi ed with the use of proprietary controls. Our evaluation of the within-run precision by internal quality control is shown as coeffi cients of variation (CVa). The results are shown in table 1. The laboratory staff (clinical chemistry specialist) contacted the patient by phone because some results (i.e. potassium, total calcium and free calcium) of the sample collected in dedicated syringe were out of the critical limits established by Kost (11, 12) . The patient reported that he did not use topical medicines or intravenous solution in the last four months. A new blood collection (serum tube and dedicated syringe only) was scheduled for 12.30 pm of the same day. The venipuncture for the 2 nd blood collection was performed, by the same phlebotomist, in cephalic vein on the left forearm. The drawing order was: a) clot activator and gel separator tube, b) blood gas dedicated-syringe; both of the same brand and lot used for the fi rst blood collection. So, during the 2 nd venipuncture the diagnostic blood specimen collection did not include a new EDTA vacuum tube. The following procedures were identical to the described above for the 1 st blood specimen collection. The 2 nd blood specimens arrived in core laboratory about 45 min after collection and were immediately processed and analyzed on the same analytical instruments. The results are shown in table 1.
Statistical analysis
The reference change values (RCV) were determined to ascertain any clinically signifi cant diff erences between the fi rst and the second blood collection according to the formula RCV = 2 
Discussion
In clinical laboratory the quality indicators are fundamental tools for quantifying the quality of a selected aspect of care by comparing it against a defi ned goal. For private laboratories the level of patient satisfaction with the diagnostic blood collection service is a very important quality indicator.
With the aim to increase the patient satisfaction the procedure described above was implemented approximately six months ago in our laboratory, in order to avoid double venipuncture. This procedure is not explicitly stated in both international and national guidelines but is frequently performed in laboratories of South America countries. In order to avoid possible test result errors due to additive carryover, the correct order of blood drawing by venipuncture should be as follows: i) blood culture tube or tube without additive; ii) sodium citrate tube; iii) serum tube with or without clot activator and with or without gel separator; iv) heparin tube with or without gel separator and/or dedicated-syringe with heparin; v) EDTA tube with or without gel separator; and vi) glycolytic inhibitor tube. (17, 18) . Unfortunately these studies did not measure the calcium values in serum tubes collected after EDTA vacuum tubes and/or vacuum tubes produced by Greiner Bio-One. Moreover we previously found that diff erent brands of in vitro diagnostic devices (e.g. vacuum tubes and syringes) have different performances in routine laboratory tests and that changes in the brands can increase laboratory variability (19) (20) (21) (22) (23) . Future investigations should be planned to cover the impact of vacuum tubes brands on EDTA carryover. Several others articles showed spurious hyperkalaemia and hypocalcemia based on EDTA carryover (24-26). Cornes et al. after measuring EDTA in 117 hyperkalaemic samples showed that spurious hyperkalaemia due to kEDTA contamination was common (about 25% of all samples tested). In the 27 patients retested, serum potassium was within the reference range confi rming the contamination with EDTA (24) . In the present case we have estimated an EDTA carryover of 0.5 ~ 0.6 mg/mL of blood into the dedicated syringe from the preceding EDTA-containing tube. It was predicted by stoichiometric calculation based on the observed reduction of Ca ions and on the molecular mass of EDTA. The estimation is based on the variation of the potassium concentration, from the K 3 EDTA tube to the syringe, taking into account that a mass concentration of 1.5 mg of K 3 EDTA per 1 mL of blood as an optimal anticoagulant level is declared (27) . The K 3 EDTA carryover is the best hypothesis to justify the spurious results found in the dedicated syringe from the 1 st blood collection. Moreover when looking at total-and free-calcium results the decreased (27) . In any case clinically signifi cant diff erences were observed for potassium, total calcium and free calcium only in the blood of the dedicated syringe when mean percent diff erences were compared with RCV derived from biological variation (Table 1 ) (28). Obviously the quality specifi cations derived from biological variation are considered both very important and useful in the daily practice by the quality managers of the medical laboratories (13, 29, 30) . Based on this depictive case we recommend the laboratory managers to train the phlebotomists as follows: 1) the dedicated needleless syringes for blood-gas must be connected to the needle-holder system immediately after serum tubes and before EDTA vacuum tubes; 2) to avoid double vein puncture the dedicated needleless syringes for free calcium determination must be connected to the needle-holder system immediately after serum tubes and before EDTA vacuum tubes.
In conclusion, we caution the laboratory managers about the current procedures advising to connect the syringes for blood gas and calcium tests at the end of all vacuum tubes; moreover we claim that the continuous training of the phlebotomists and Bold values are results outside of critical limits (11, 12) and bold mean % diff erences represent clinically signifi cant variations, when compared with reference change value (RCV). NA -not applied; CVa -analytical within run precision of the internal quality control, CVw -coeffi cient of variation within-subject (13). of all the laboratory staff with regards to the effects of preanalytical interferences is a mandatory task in every modern clinical laboratory.
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